QINLOCK

ripretinib · Deciphera Pharmaceuticals, LLC

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for QINLOCK, covering 2020-05-15 to 2026-08-27. Get the full timeline:

Most recent: EMA Authorised: Qinlock (ripretinib) — Deciphera Pharmaceuticals (Netherlands) B.V.